IP Laws Bill progressed after Productivity Commission Report
06 June, 2013The federal government has moved to amend intellectual property Crown use provisions following recommendations in the Productivity Commission Inquiry Report on the compulsory licensing of patents.
Consegna trials BreatheAssist in athletes
06 June, 2013 by Dylan Bushell-EmblingConsegna (ASX:CGP) said two thirds of athletes trialling the prototype of the sport version of its BreatheAssist device felt they were able to take more air into their lungs.
Bioniche signs licensing, funding deal with Paladin
06 June, 2013 by Dylan Bushell-EmblingBioniche (ASX:BNC) has entered a debt refinancing, funding and Urocidin licensing agreement with Canada’s Paladin Labs.
Mesoblast wins Japanese patent for stem cell platform
05 June, 2013 by Dylan Bushell-EmblingMesoblast (ASX:MSB) has secured a Japanese patent offering broad protection for its MPC adult stem cell platform in the market through to 2025.
FB Rice names Melbourne biotech partners
05 June, 2013 by Dylan Bushell-EmblingAustralian intellectual property advisory firm FB Rice has appointed two new partners for its Melbourne biotechnology and chemistry practice.
ResMed launches online sleep breathing tool
04 June, 2013 by Dylan Bushell-EmblingResMed (ASX:RMD) has launched a new online - and soon mobile - app to help sleep-disordered breathing patients track their therapy progress and set goals.
Immuron to sell Travelan straight to wholesalers
04 June, 2013 by Dylan Bushell-EmblingImmuron (ASX:IMC) has dissolved its relationship with ANZ distributor Takeda and will start selling its flagship Travelan product directly to wholesalers in the markets.
Manufacturing CRC invites participation
04 June, 2013A new Cooperative Research Centre (CRC) for Manufacturing Industry Innovation (MIICRC) invites organisations to participate as industry partners.
Cochlear shares slump on word of weaker sales
04 June, 2013 by Dylan Bushell-EmblingCochlear Limited (ASX:COH) revealed its 2H sales have been lower as its customers awaited the now-in-process launch of its Nucleus 6 sound management product line.
FDA blocks imports of Pharmaxis asthma test
03 June, 2013 by Dylan Bushell-EmblingThe US FDA has added Pharmaxis’s Aridol to its Import Alert list, preventing the company from shipping units of the asthma test into the market.
Another pharma evaluating pSivida’s Durasert
30 May, 2013 by Dylan Bushell-EmblingpSivida (ASX:PVA) has signed an evaluation agreement with an unnamed global pharmaceutical company covering its Durasert ophthalmic insert.
AusBiotech investment summit heading for Melbourne
30 May, 2013Australia Biotech Invest 2013, the largest life science investment meeting in Australia, will this year be held on 28 and 29 October at the Melbourne Convention and Exhibition Centre.
Design your own bacteria in one step
30 May, 2013 by Lauren DavisThe production of designer bacteria for biotechnology processes used to be an inefficient one. Now, University of Adelaide researchers have developed a new method that is simple and fast.
Immuron picks new director
29 May, 2013Immuron (ASX:IMC) has named 20-year healthcare industry veteran Stephen Anastasiou as a new non-executive director.
Pharmaxis to cut 30% of jobs in restructuring
28 May, 2013 by Dylan Bushell-EmblingPharmaxis (ASX:PXS) has announced plans to cut 30% of its workforce and consolidate its manufacturing facilities, and seek partners for much of its Bronchitol commercialisation efforts.
